RDTC Logo

Regional Drug & Therapeutics Centre

University Emblem

  Page: Services - Yellow Card Centre Northern & Yorkshire - MHRA/CHM safety information

     Helping to make medicines safer

 

Home
About us
Management
Publications
Education
Services
Links
Contact us
Search
tablets
tablets

Yellow Card Centre Northern & Yorkshire
 

Adverse Drug Reaction Monitoring
 

MHRA/CHM safety information

Drug Safety Update

A new monthly newsletter from the MHRA and CHM, which aims to provide information and advice about the safe use of medicines. It is intended for all healthcare professionals who work in the UK – doctors, pharmacists, nurses, non-medical prescribers, dentists, allied health professionals and coroners.

 

 

Latest issue of Drug Safety Update

Previous issues of Current Problems in Pharmacovigilance

 

 

Safety warnings

Monthly newsletter on safety information sent to healthcare professionals

Medicines

Herbal medicines

 

 

Product specific information and advice

The MHRA provides information on the following groups of drugs which are under close surveillance, due to serious or emerging safety concerns.

Alpha-adrenoceptor agonists and intraoperative floppy iris syndrome

Antiepileptics

Antipsychotic drugs

Antiretroviral drugs for HIV

Asthma: long acting beta-2 agonists

Bisphosphonates

Cardiovascular safety of Cox-2 inhibitors and
non-selective NSAIDs

Dopamine agonists for Parkinson’s disease

Glitazones for diabetes

Hormonal contraceptives

Hormone Replacement Therapy (HRT)

Human Papillomavirus (HPV) Vaccine

Isotretinoin for severe acne

Latex reactions (allergies) and medical devices

Measles, mumps and rubella (MMR) vaccine

Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors

Steroid medicines

'Stop smoking' treatments

Swine flu

Thiomersal (ethylmercury) containing vaccines

Vaccine safety

 

Drug Analysis Prints

Drug Analysis Prints (DAPs) are complete listings of all suspected adverse drug reactions reported to the MHRA via the Yellow Card Scheme by healthcare professionals and patients. These can be accessed from the MHRA website, along with guidance for their interpretation

 

 

Questions and Answers on Drug Analysis Prints

 

 

Q1. If a reaction is listed on a DAP for a particular drug, does this mean that the drug has caused it?

Q2. Can the information in the DAP be used to determine the likelihood of an ADR to a particular medicine occurring?

Back button

YCC pages:

spacer

 

YCC About Us

 

 

Yellow Card Scheme

 

 

Patient Reporting

 

spacer 

MHRA/CSM Safety Info

 

 

Educational Tools

 

 

NMS and ADR
Reporting

 

spacer 

Publications

spacer

 

 

SMU

 

 

 

Annual Reports

 

 

YCC Useful Links

 

Page last updated 05/03/2012

line

Site Disclaimer 

Privacy Statement 

Feedback 

Site Map 

Copyright 

link

RSS FeedRSS Feed

Site last updated 24/05/2012

spacer
valid-html